Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study

The cerebrovascular safety and efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus (T2DM) with ischemic stroke remains uncertain. The aim of this study was to assess the efficacy and safety of sitagliptin in patients with T2DM with recent ischemic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dong-Yi, Wang, Szu-Heng, Mao, Chun-Tai, Tsai, Ming-Lung, Lin, Yu-Sheng, Su, Feng-Chieh, Chou, Chung-Chuan, Wen, Ming-Shien, Wang, Chun-Chieh, Hsieh, I-Chang, Hung, Kuo-Chun, Cherng, Wen-Jin, Chen, Tien-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617065/
https://www.ncbi.nlm.nih.gov/pubmed/26181549
http://dx.doi.org/10.1097/MD.0000000000001128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617065/
https://www.ncbi.nlm.nih.gov/pubmed/26181549
http://dx.doi.org/10.1097/MD.0000000000001128

Ejemplares similares